Navigation Links
Amorcyte Reports Phase I Results of AMR-001 to Improve Recovery From Severe Heart Attack at ACC Annual Scientific Session
Date:3/30/2009

for heart failure and need for repeat vascularization. Strikingly, this analysis found a significant association between injected cell volume and improvement in ejection fraction that is suggestive of a dose effect. This summation of prior studies supports Amorcyte's subsequent prospective findings.

"Having successfully confirmed a dose effect, Amorcyte looks forward to proceeding with a larger prospective randomized trial and furthering our clinical program with AMR-001," said Andrew Pecora, M.D., Chairman of the Board of Amorcyte. "These strong Phase I results, combined with proprietary innovative technologies that address the challenges of commercializing stem cell products, position us to bring to market a stem cell therapy with the potential to address a serious unmet patient need."

About Cardiovascular Disease

It is estimated that each year there are approximately 1.1 million instances of acute myocardial infarction (AMI). 160,000 AMIs are severe enough to cause ventricular remodeling leading to further tissue damage over time and downstream adverse events including premature death, recurrent myocardial infarction, congestive heart failure, significant arrhythmias and acute coronary syndrome. Amorcyte's therapy aims to limit ventricular remodeling.

About Amorcyte, Inc.

Amorcyte is a privately held biotechnology company developing cell therapy products to treat cardiovascular disease. Its lead product AMR-001, for the prevention of major adverse cardiac events following acute myocardial infarction (AMI), has completed Phase I clinical trials demonstrating feasibility, safety and biologic activity at a threshold dose. This is the first stem cell trial in AMI ever conducted that has prospectively established a significant relationship between dose and effect. Amorcyte has partnered with Progenitor Cell Therapy, a leading provider of clinical, manufacturing and ot
'/>"/>

SOURCE Amorcyte, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. TorreyPines Therapeutics Reports Fourth Quarter and Full Year 2008 Results
2. Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2008 Financial Results
3. Cornerstone Therapeutics Reports Year Ended December 31, 2008 Financial Results
4. ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2008 Financial Results
5. Cell Therapeutics, Inc. Reports Outcome of Special Meeting of Shareholders
6. China Bio Energy Reports Fourth Quarter and Record 2008 Financial Results
7. Neogen Reports Record Third Quarter
8. Transgenomic, Inc. Reports Fourth Quarter and Fiscal Year 2008 Results
9. Champions Biotechnology Reports Fiscal 2009 Third Quarter Financial Results
10. BMP Sunstone Reports Fourth Quarter and Full Year 2008 Financial Results
11. Medivation Reports Fourth Quarter and Year-End 2008 Financial Results and Provides Corporate Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... 2015 Achieved primarily through a proprietary ... boast 10 to 100x better detail than the industry ... all existing light microscopy methods, it needed another medium ... as the frame of reference because it represents the ... goal from the earliest discovery days of Ultralight Histology ...
(Date:5/4/2015)... 2015   Intrexon Corporation (NYSE: XON ... financial results after the market closes on May 11, ... day at 5:30 PM ET to discuss the results ... conference call may be accessed by dialing 1-888-346-3959 (Domestic ... "Intrexon Conference Call."  Participants may also access the live ...
(Date:5/1/2015)... , May 1, 2015 /PRNewswire/ - BioAmber Inc. (NYSE: ... chemicals, today announced that it has priced an underwritten registered ... a price of $9.00 per share, and granted the ... up to an additional 585,000 shares of its common ... $35.1 million.  The offering is expected to close on May ...
(Date:5/1/2015)... 2015 Albany Molecular Research Inc. (NASDAQ: ... , AMRI,s President and Chief Executive Officer, will present ... Care Conference on Wednesday, May 13, 2015 at 4:20 ... the presentation can be accessed at AMRI,s Investor Relations ... webcast will be archived for 90 days following the ...
Breaking Biology Technology:Intrexon to Announce First Quarter 2015 Financial Results on Monday, May 11, 2015 2BioAmber Inc. Announces Pricing Of $35.1 Million Registered Offering 2BioAmber Inc. Announces Pricing Of $35.1 Million Registered Offering 3AMRI to Present at the Bank of America Merrill Lynch 2015 Health Care Conference 2
... to a multiplex near you, but movies showing the ... have blockbuster potential. A team of scientists with the ... of California (UC) Berkeley has developed a technique for ... that chemical reactions in the liquids can be imaged ...
... development of new applications based on nanoimprinting techniques (NIL) is ... challenges to be overcome in order to reach the market? ... its uptake from the industry? What are the tools needed ... exactly with this topic, i.e. Nanopatterning, Production and Applications based ...
... 20, 2012     On May 21-23, 2012, ... created to support, mentor, and develop minority-, woman-, ... host its fifth annual networking conference and EXPO ... health advocate, will address the conference held at ...
Cached Biology Technology:First atomic-scale real-time movies of platinum nanocrystal growth in liquids 2First atomic-scale real-time movies of platinum nanocrystal growth in liquids 3First atomic-scale real-time movies of platinum nanocrystal growth in liquids 4First atomic-scale real-time movies of platinum nanocrystal growth in liquids 5Low-cost optical components through nanoimprinting lithography 2Low-cost optical components through nanoimprinting lithography 3Music Legend And Health Advocate Bret Michaels To Address Diversity Alliance For Science 2012 National Conference And EXPO 2Music Legend And Health Advocate Bret Michaels To Address Diversity Alliance For Science 2012 National Conference And EXPO 3
(Date:4/27/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... the growing mobile commerce market, announces that its Wocket® ... first week of May, 2015 and will be fulfilling ... Gino Pereira , Chief Executive Officer ... as Wocket® enters the consumer market. We would like ...
(Date:4/21/2015)... 21, 2015 High crime ... are boosting access control systems market in ... a recently published report by TechSci Research " Saudi ... access control systems market in Saudi Arabia ... 2020.The access control systems market in the Kingdom is ...
(Date:4/20/2015)... 2015 The announcement comes as ... Records Management (GRM), Ireland,s foremost records ... Having built up an impressive track record of clients within ... within the records management sector in Dubai ... GCC staffbase and employ a further eight staff members at ...
Breaking Biology News(10 mins):Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 3Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 2Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 3Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 2Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 3
... Americans, protects some people with heart failure, enabling them ... a research team led by investigators at the University ... Washington University School of Medicine in St. Louis. The ... beta-blockers, a class of drugs used to treat chronic ...
... computer simulation has revealed a self-healing behavior in ... of radiation-resistant materials for nuclear power plants and ... of Energy,s Pacific Northwest National Laboratory found that ... damage in the engineered ceramic yttria-stabilized zirconia. ...
... shows clearly that powerful starquakes ripple around the Sun in ... surface. The observations give solar physicists new insight into a ... studying other stars. The outermost quarter of the Suns ... in this region causes ripples that criss-cross the solar surface, ...
Cached Biology News:Genetic variant mimics effect of heart failure medications 2Genetic variant mimics effect of heart failure medications 3Genetic variant mimics effect of heart failure medications 4Ceramic, heal thyself 2Solar flares set the Sun quaking 2
Imject Freund's Incomplete Adjuvant (FIA)...
... LTQ XL extends the MSn performance of ... new tools to generate extensive structural information ... applications. , Multiple dissociation techniques (PQD, ... and unpredicted metabolites , Fast polarity switching ...
... - Utilizes hands-off homogenization through a vortex adapter ... - Extract DNA without hand grinding; eliminating the ... , Robust tubes - Includes tough customized ... breakage , Flexible format - Compatible ...
... The LXQ linear ion trap mass ... paced analytical laboratory., The LXQ linear ion ... discovery and proteomic applications, delivering the fast ... Thermo linear ion trap at an attractive ...
Biology Products: